Windsor Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.83M | Sell |
14,216
-1,366
| -9% | -$160K | 0.47% | 42 |
|
|
2026
Q1 | $1.87M | Buy |
15,582
+52
| +0.3% | +$6K | 0.53% | 38 |
|
|
2025
Q4 | $1.63M | Buy |
15,530
+29
| +0.2% | +$2.72K | 0.45% | 40 |
|
|
2025
Q3 | $1.3M | Sell |
15,501
-646
| -4% | -$53.2K | 0.36% | 44 |
|
|
2025
Q2 | $1.28M | Sell |
16,147
-519
| -3% | -$41.3K | 0.37% | 45 |
|
|
2025
Q1 | $1.5M | Sell |
16,666
-216
| -1% | -$20.2K | 0.46% | 40 |
|
|
2024
Q4 | $1.68M | Sell |
16,882
-688
| -4% | -$70.9K | 0.5% | 39 |
|
|
2024
Q3 | $2M | Sell |
17,570
-484
| -3% | -$57.5K | 0.58% | 35 |
|
|
2024
Q2 | $2.24M | Sell |
18,054
-56
| -0.3% | -$7.21K | 0.69% | 32 |
|
|
2024
Q1 | $2.39M | Sell |
18,110
-237
| -1% | -$29.2K | 0.74% | 31 |
|
|
2023
Q4 | $2M | Sell |
18,347
-161
| -0.9% | -$16.7K | 0.65% | 32 |
|
|
2023
Q3 | $1.91M | Buy |
18,508
+302
| +2% | +$32.5K | 0.66% | 32 |
|
|
2023
Q2 | $2.1M | Sell |
18,206
-241
| -1% | -$27.4K | 0.7% | 30 |
|
|
2023
Q1 | $1.96M | Sell |
18,447
-429
| -2% | -$46.3K | 0.68% | 31 |
|
|
2022
Q4 | $2.09M | Sell |
18,876
-574
| -3% | -$58.7K | 0.76% | 29 |
|
|
2022
Q3 | $1.68M | Sell |
19,450
-207
| -1% | -$18.5K | 0.63% | 33 |
|
|
2022
Q2 | $1.79M | Sell |
19,657
-16
| -0.1% | -$1.42K | 0.64% | 32 |
|
|
2022
Q1 | $1.61M | Buy |
19,673
+438
| +2% | +$34.5K | 0.5% | 39 |
|
|
2021
Q4 | $1.47M | Buy |
19,235
+413
| +2% | +$32.9K | 0.44% | 43 |
|
|
2021
Q3 | $1.41M | Sell |
18,822
-124
| -0.7% | -$9.43K | 0.45% | 42 |
|
|
2021
Q2 | $1.47M | Sell |
18,946
-997
| -5% | -$74.2K | 0.49% | 39 |
|
|
2021
Q1 | $1.47M | Sell |
19,943
-209
| -1% | -$15.4K | 0.51% | 39 |
|
|
2020
Q4 | $1.57M | Buy |
20,152
+781
| +4% | +$59.7K | 0.59% | 39 |
|
|
2020
Q3 | $1.53M | Sell |
19,371
-135
| -0.7% | -$10.6K | 0.64% | 36 |
|
|
2020
Q2 | $1.44M | Buy |
19,506
+6,307
| +48% | +$475K | 0.62% | 36 |
|
|
2020
Q1 | $969K | Sell |
13,199
-77
| -0.6% | -$6.05K | 0.49% | 43 |
|
|
2019
Q4 | $1.15M | Buy |
13,276
+485
| +4% | +$39.8K | 0.48% | 48 |
|
|
2019
Q3 | $1.03M | Buy |
12,791
+348
| +3% | +$27.9K | 0.46% | 55 |
|
|
2019
Q2 | $995K | Buy |
12,443
+191
| +2% | +$14.6K | 0.46% | 55 |
|
|
2019
Q1 | $972K | Sell |
12,252
-327
| -3% | -$24.5K | 0.46% | 55 |
|
|
2018
Q4 | $917K | Buy |
12,579
+545
| +5% | +$38.5K | 0.47% | 54 |
|
|
2018
Q3 | $814K | Buy |
12,034
+42
| +0.4% | +$2.68K | 0.37% | 66 |
|
|
2018
Q2 | $694K | Sell |
11,992
-399
| -3% | -$22.5K | 0.32% | 71 |
|
|
2018
Q1 | $644K | Buy |
12,391
+3,069
| +33% | +$166K | 0.3% | 71 |
|
|
2017
Q4 | $500K | Buy |
9,322
+584
| +7% | +$32.4K | 0.23% | 84 |
|
|
2017
Q3 | $534K | Hold |
8,738
| – | – | 0.27% | 74 |
|
|
2017
Q2 | $534K | Buy |
8,738
+339
| +4% | +$20.6K | 0.27% | 75 |
|
|
2017
Q1 | $509K | Sell |
8,399
-735
| -8% | -$44.6K | 0.26% | 77 |
|
|
2016
Q4 | $513K | Buy |
9,134
+384
| +4% | +$22.5K | 0.28% | 78 |
|
|
2016
Q3 | $521K | Buy |
8,750
+376
| +4% | +$22K | 0.29% | 76 |
|
|
2016
Q2 | $460K | Buy |
8,374
+673
| +9% | +$35.8K | 0.27% | 77 |
|
|
2016
Q1 | $388K | Buy |
7,701
+260
| +3% | +$12.7K | 0.24% | 81 |
|
|
2015
Q4 | $375K | Sell |
7,441
-98
| -1% | -$4.94K | 0.23% | 77 |
|
|
2015
Q3 | $355K | Sell |
7,539
-498
| -6% | -$26.5K | 0.21% | 78 |
|
|
2015
Q2 | $436K | Buy |
8,037
+1,128
| +16% | +$63.3K | 0.25% | 70 |
|
|
2015
Q1 | $379K | Buy |
6,909
+1,300
| +23% | +$73.6K | 0.22% | 75 |
|
|
2014
Q4 | $304K | Buy |
5,609
+46
| +0.8% | +$2.56K | 0.17% | 82 |
|
|
2014
Q3 | $315K | Sell |
5,563
-2,069
| -27% | -$116K | 0.18% | 73 |
|
|
2014
Q2 | $421K | Buy |
7,632
+455
| +6% | +$24.8K | 0.24% | 60 |
|
|
2014
Q1 | $389K | Buy |
7,177
+448
| +7% | +$23.2K | 0.23% | 60 |
|
|
2013
Q4 | $321K | Buy |
6,729
+1,400
| +26% | +$64K | 0.19% | 63 |
|
|
2013
Q3 | $242K | Buy |
5,329
+565
| +12% | +$25.8K | 0.14% | 72 |
|
|
2013
Q2 | $211K | Buy |
+4,764
| New | +$213K | 0.13% | 75 |
|
Other funds holding MRK
ECSS
Windsor Capital Management's MRK Position: Q2 2026 in Review
Windsor Capital Management reduced its Merck (MRK) stake by 8.8% in Q2 2026, selling an estimated $160K and leaving 14,216 shares worth $1.83M. The position accounts for 0.47% of the portfolio, ranked #42.
Windsor Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.39M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Windsor Capital Management held 14,216 shares of Merck worth $1.83M as of Q2 2026.
- Windsor Capital Management sold 1,366 Merck shares in Q2 2026, an estimated $160K.
- Merck made up 0.47% of Windsor Capital Management's portfolio in Q2 2026, its #42 holding.
- Windsor Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Windsor Capital Management's Merck position peaked at $2.39M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.